Skip to main content

Quest Diagnostics is bringing a new perspective to this year's American Society of Reproductive Medicine (ASRM) Scientific Congress. Stop by booth #1001, or schedule an appointment with our team using the link below, to discover how our unified reproductive health solutions help strengthen your care models and support patients every step of the way.

Let's meet at ASRM

  • See how our integrated lab solutions deliver a complete fertility testing solution
  • Learn how we work with practices to help reduce complexity and save time
  • Explore ways we can help you enhance patient trust and experience across the fertility journey

Aligning diagnostics to every protocol and patient path

Our broad, patient-aligned solutions support individualized care planning and flex to match the timing, complexity, and sequencing of each patient journey, whether you're identifying the cause of infertility or managing pregnancy outcomes.

 

Broad portfolio of clinically relevant, right-sized solutions for patients

QHerit® carrier screening

Carrier screening is an essential part of preconception and fertility care, helping identify potential genetic risks before treatment begins. QHerit offers 5 panel options and screens for up to 611 conditions so you can match the appropriate level of screening to each patient's unique journey. 

 

By providing clear, actionable insights, we support you in counseling patients with confidence, improving reproductive decision-making, and helping families move forward with clarity.

Cheerful doctor talking with his patient in doctors office at hospital.

SIMPLIFYING DONOR SCREENING WITH PRECISION AND SPEED

Reproductive donor testing

As part of our specialized fertility solutions, our reproductive donor testing delivers the speed, convenience, and accuracy you need, without the complexity. With an extensive menu for both male and female donors and a simplified ordering process through your EMR and/or Quanum® Lab Services Manager, we aim to make the process easier. 
 

In addition, our dedicated customer service team provides white-glove support to help ensure your donor testing needs are met with precision and care at every step. 

 

 

shutterstock_633287753-shorten-arm.jpg

SPECIALIZED AND IN-DEPTH ANALYSIS OF A MAN'S SPERM

Sperm DNA fragmentation

A semen analysis is often the first male fertility test that a fertility specialist will order for a man. While it provides valuable information about certain parameters of sperm health, it can’t provide detailed information about factors like sperm-DNA fragmentation. This is the reason our proprietary Advanced Semen Report can be so beneficial for your male patients and their partners.

 

Using just a single specimen, our sperm DNA testing provides information about sperm quality that goes beyond the results of a routine semen analysis. Research indicates that live-birth rates for natural conception and intrauterine insemination (IUI) can be dramatically reduced in couples where the man has high levels of sperm-DNA fragmentation damage. This same research also indicates that 20% to 30% of men from couples seeking an infertility evaluation may have abnormally high levels of fragmentation.

 

Doctor In Consultation With Male Patient In Office

COMPREHENSIVE SEMEN ANALYSIS

Sperm analysis

A semen analysis is a vital diagnostic tool for every fertility specialist. However, many men are intimidated by the thought of providing a semen sample away from home. The ReproSource Semen Analysis with @Home Collection solves this problem by offering a convenient and highly accurate at-home option. At-home collection is perfect for patients who prefer the privacy of collecting a specimen at home as well as remote patients who live far away from your office. Clinics without on-site collection and analysis capabilities can also benefit from this option.

 

 

sales rep speaking with doctor

ReproSource is a national leader in specialty fertility diagnostic services. While ReproSource is a Quest Diagnostics affiliate, ReproSource and Quest are separate companies. As such, health plan access, test ordering, and billing processes may differ from those of Quest Diagnostics. Please note that ReproSource is not a Medicare/Medicaid provider. For more information, please contact ReproSource at 1.800.667.8893 or visit ReproSource.com/Contact.

QHerit® 6, QHerit 28, QHerit 112, QHerit 198, QHerit 445, QHerit 611, and QHerit Flex are carrier screening tests, and they screen for variations in genes linked to certain health disorders that can be passed from parents to children. QHerit 6 screens for 7 genes, QHerit 28 screens for 29 genes, QHerit 112 screens for 113 genes, QHerit 198 screens for 199 genes, QHerit 445 screens for 446 genes, QHerit 611 screens for 612 genes, and QHerit Flex screens of up to 10 genes. For a full list of genes that each panel in the QHerit family screens, visit QHerit.com. If the results from any panel in the QHerit family suggest that a patient may be a carrier for a gene variation that can cause a health disorder in her offspring, it is recommended that her reproductive partner be offered genetic screening, and that genetic counseling be provided. Pregnancy management decisions should not be based on the results of these screening tests alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic variation and may be lower for rare conditions. Each panel in the QHerit family is a laboratory-developed test that has been developed and validated pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA) and as such, it has not been reviewed by FDA.